tiprankstipranks
Trending News
More News >
Consun Pharmaceutical Group Ltd. (HK:1681)
:1681
Hong Kong Market

Consun Pharmaceutical Group Ltd. (1681) Income Statement

Compare
6 Followers

Consun Pharmaceutical Group Ltd. Income Statement

Last quarter (Q4 2024), Consun Pharmaceutical Group Ltd.'s total revenue was ¥1.70B, an increase of 26.19% from the same quarter last year. In Q4, Consun Pharmaceutical Group Ltd.'s net income was ¥510.69M. See Consun Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 2.97B¥ 2.59B¥ 2.34B¥ 2.04B¥ 1.75B
Gross Profit
¥ 2.24B¥ 1.92B¥ 1.76B¥ 1.53B¥ 1.32B
Operating Expenses
¥ 1.20B¥ 1.04B¥ 1.06B¥ 857.82M¥ 744.42M
Depreciation and Amortization
¥ 71.58M¥ 78.09M¥ 76.36M¥ 72.99M¥ 71.80M
EBITDA
¥ 1.05B¥ 963.06M¥ 785.89M¥ 728.71M¥ 618.79M
Operating Income
¥ 1.05B¥ 884.97M¥ 715.41M¥ 660.18M¥ 550.13M
Other Income/Expenses
¥ -24.95M¥ -21.26M¥ 30.98M¥ 35.68M¥ 33.61M
Pretax Income
¥ 1.02B¥ 863.70M¥ 746.39M¥ 695.86M¥ 583.74M
Net Income
¥ 910.46M¥ 784.53M¥ 682.91M¥ 590.17M¥ 498.79M
Per Share Metrics
Basic EPS
¥ 1.11¥ 0.98¥ 0.86¥ 0.74¥ 0.61
Diluted EPS
¥ 1.09¥ 0.98¥ 0.86¥ 0.73¥ 0.61
Weighted Average Shares Outstanding
821.10M 800.54M 790.63M 801.58M 817.26M
Weighted Average Shares Outstanding (Diluted)
832.11M 799.17M 792.00M 804.70M 817.26M
Currency in CNY

Consun Pharmaceutical Group Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis